Literature DB >> 15351464

[High frequency ultrasonography and celluscore: an improvement in the objective evaluation of cellulite phenomenon].

B Mole1, P Blanchemaison, D Elia, M Lafontan, J Mauriac, M Mauriac, S Mimoun, J Raison.   

Abstract

As they usually do not have any serious effect on health condition, cellulite phenomenons are not considered as potentially hazardous by general practitioners; unfortunately they involve almost all the feminine population after the forties and may really induce bad side effects either psychological or physical whatever the confusing origin of that cutaneous deformation: heredity, nutrition, circulatory and hormonal diseases etc. Trying to appreciate in a more scientific way this superficial skin disorder, we have developed a computerised questionnaire which can be combined with the finest upto date way of skin exploration, high frequency ultrasonography. It seems possible to consider now cellulite as the result of various disorders which can be separate into fibrotic or retentional phenomenons (surrounding superficial fat tissues) and the direct adipocyte reaction (adiposis). We hope to be able in the future to extend the treatment of cellulite beyond the limits of liposuction which seems until today the only way to bring some improvement to that phenomenon in spite of the very delicacy of the surgical approach.

Entities:  

Mesh:

Year:  2004        PMID: 15351464     DOI: 10.1016/j.anplas.2004.06.005

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  2 in total

Review 1.  Can cellulite be treated with low-energy extracorporeal shock wave therapy?

Authors:  Fiorenzo Angehrn; Christoph Kuhn; Axel Voss
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

2.  Impact of extracorporeal shock waves on the human skin with cellulite: a case study of an unique instance.

Authors:  Christoph Kuhn; Fiorenzo Angehrn; Ortrud Sonnabend; Axel Voss
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.